Rezultati pretraživanja
  1. prije 5 sati

    has 1st Peanut Allergy Drug but not the last - have a Breakthrough Designation in General Food Allergy for Xolair (Omalizumab) already Approved in asthma-top line data in 8 mos in Severe drug allergies. Many refer to as only competition - isn’t so.

  2. prije 8 sati

    : Bristol-Myers’ Opdivo-Yervoy NSCLC Application in EU Withdrawn:

  3. prije 12 sati

    3 Big Drugmakers Are Taking On the Coronavirus

    2 korisnika označavaju da im se sviđa
  4. prije 14 sati

    short squeeze on Filings coming.. Get your tickets. The DD is not shabby either. Company being run by 2 Nasdaq execs.

    2 korisnika označavaju da im se sviđa
  5. prije 15 sati

    : Gilead Might Have a Coronavirus Treatment. Its Stock Is Set to Rise.:

  6. 3. velj

    Big News - Major Stakeholder -- Stuart Yarbrough - No longer Director of Cision LTD - Cision gets Acquired. -- He helps funds companies! Full attention towards MILV 🤑

    1 reply 7 proslijeđenih tweetova 9 korisnika označava da im se sviđa
  7. 3. velj

    Back In Red Ink

  8. 2. velj

    Why Is Microsoft Investing in Adaptive Biotechnologies?

  9. 31. sij

    - Roche Still Going Strong, As Pipeline Productivity Fuels Pharma Growth.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  10. 31. sij

    bets big on Tigit, and that should be of interest to & others. Updated story via

    6 proslijeđenih tweetova 16 korisnika označava da im se sviđa
  11. 31. sij

    transcript on

    9 proslijeđenih tweetova 35 korisnika označava da im se sviđa
  12. 30. sij

    In summary: is making a massive bet on Tigit

    6 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  13. 30. sij

    What to make of Pharmamar’s PR saying it’s developing a coronavirus assay, to be available in 5-7 weeks? Hasn’t got there already?

    1 reply 2 korisnika označavaju da im se sviđa
  14. 30. sij

    Bill Anderson: Skyscraper-02 study “starting very soon”

    1 reply 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  15. 30. sij

    It has to be said - that’s a lot of 2020 filings

    1 proslijeđeni tweet 8 korisnika označava da im se sviđa
  16. 30. sij

    This is Roche. Discover our facts & figures for 2019:

    1 reply 7 proslijeđenih tweetova 25 korisnika označava da im se sviđa
  17. 30. sij

    : Roche (RHHBY) 2019 Sales Solid on Robust Show by New Drugs:

  18. 30. sij

    First time I've heard mention the Skyscraper-02 trial (Tecentriq + tiragolumab + chemo in SCLC).

    1 reply 1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  19. 30. sij

    Good illustration of how biosimilars are hitting . Novel me-too drugs are accelerating, but it's not enough.

    5 proslijeđenih tweetova 9 korisnika označava da im se sviđa
  20. 29. sij

    Seattle Genetics Gets Speedy FDA Nod for Bladder Cancer Drug

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.